Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD, and gE

  • 160 Accesses

  • 32 Citations

Summary

We have improved the method for constructing recombinants of bovine herpesvirus type-1 (BHV-1). Using this method, we constructed three recombinants in which the pseudorabies virus (PRV) thymidine kinase (tk) gene was inserted at three different sites in the unique short region of BHV-1. These three sites are located in the open reading frame of gE, gG and gI genes. Previously, two sites (tk and gC) had been used to insert foreign DNA fragments to BHV-1 genome. Therefore we now have 5 sites in BHV-1 where DNA can be inserted. The gB, gC, gD, gE and gI genes of PRV were successfully inserted at the tk or the gC gene of BHV-1 genome and Western blot analyses confirmed that the recombinants express PRV gB, gC, gD and gE. Anti-PRV gB and gC antibodies as well as anti-PRV polyclonal serum neutralized BHV-1 recombinants which express PRV gB and gC. The latter was neutralized more strongly. However, anti-gD monoclonal antibody and anti-PRV polyclonal serum failed to neutralize gD-expressing recombinants. This suggests that PRV gC and some gB are integrated into the viral envelope of the recombinants, but very little gD is present in the viral envelope.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Aswell JF, Allen GP, Jamieson AT, Campbell DE, Gentry GA (1977) Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro. Antimicrob Agents Chemother 12: 243–254

  2. 2.

    Balan P, Davis-Poynter N, Bell S, Atkins H, Browne H, Minson T (1994) An analysis of the in vitro phenotypes of mutants of herpes simplex virus type 1 lacking glycoprotein gG, gE, gI or the putative gJ. J Gen Virol 75: 1245–1258

  3. 3.

    Coe NE, Mengeling WL (1990) Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of Indiana-Funkhauser strain of pseudorabies virus. Arch Virol 110: 137–142

  4. 4.

    Engels M, Giuliani C, Wild P, Beck TM, Loepfe E, Wyler R (1986) The genome of bovine herpesvirus 1 (BHV-1) strains exhibiting a neuropathogenic potential compared to known BHV-1 strains by restriction site mapping and cross-hybridization. Virus Res 6: 57–73

  5. 5.

    Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M (1987) Lipofection: A highly efficient, lipid mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413–7417

  6. 6.

    Flores EF, Osario FA, Zanella L, Kit S, Kit M (1993) Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals. J Vet Diagn Invest 5: 534–540

  7. 7.

    Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND (1988) Herpes simplex virus immunogloblin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62: 1347–1354

  8. 8.

    Kit S, Dubbs DR, Freason PM (1966) HeLa cells resistant to bromodeoxyuridine and deficient in thymidine kinase activity. Int J Cancer 1: 19–30

  9. 9.

    Kit M, Kit S (1991) Sensitive glycoprotein gIII blocking ELISA to distinguish between pseudorabies (Aujeszky's disease)-infected and vaccinated pigs. Vet Microbiol 28: 141–155

  10. 10.

    Kit S, Kit M, DiMarchi RD, Little SP, Gale C (1991) Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot and mouth disease capsid protein epitopes on surface of hybrid virus particles. Arch Virol 120: 1–17

  11. 11.

    Kit M, Kit S, Little SP, DiMarchi RD, Gale C (1991) Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot and mouth disease epitopes. Vaccine 9: 564–572

  12. 12.

    Kit M, Kit S, Otsuka H (1990) Infectious bovine rhinotracheitis virus mutants, vaccines containing same and methods for production of same and methods for use of same. United States Patent No. 4, 992, 051. Issued 7/17/90. Canadian Patent No. 1,299,121 April 21, 1992

  13. 13.

    Kit S, Otsuka H, Kit M (1992) Expression of porcine pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector. Arch Virol 124: 1–20

  14. 14.

    Kit S, Qavi H, Dubbs DL, Otuska H (1983) Attenuated marmoset herpesvirus isolated from recombinants of virulent marmoset herpesvirus and hybrid plasmids. J Med Virol 12: 25–36

  15. 15.

    Leung-Tack P, Audonnet J-C, Riviere M (1994) The complete DNA sequence and the genetic organization of the short unique region (Us) of the bovine herpesvirus type 1 (ST strain). Virology 199: 409–421

  16. 16.

    Lominiczi B, Watanabe S, Ben-Porat T, Kaplan AS (1987) Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus. J Virol 61: 796–801

  17. 17.

    Longnecker R, Roizman B (1987) Clustering of genes dispensable for growth in culture in the S component of the HSV-1 genome. Science 236: 573–576

  18. 18.

    Longnecker R, Chatterjee S, Whitley RJ, Roizman B (1987) Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci USA 84: 4303–4307

  19. 19.

    Matsukage A, Ono K, Ohashi A, Takahashi T, Nakayama C, Saneyoshi M (1978) Inhibitory of 1-′-D-arabinofuranosylthymine-5′-triphosphate and 1-′-D-arabinofuranosylcytosine-5′-triphosphate on DNA polymerase from murine cells and onconavirus. Cancer Res 38: 3076–3079

  20. 20.

    Mayfield JE, Good PJ, VanOort HJ, Campbell AR, Reed DE (1983) Cloning and cleavage site mapping of DNA from bovine herpesvirus 1 (Cooper strain). J Virol 47: 259–264

  21. 21.

    Mettenleiter TC, Lukacs N, Rziha H-J (1985) Mapping of the structural gene of pseudorabies virus glycoprotein A and identification of two non-glycosylated precursor polypeptides. J Virol 53: 52–57

  22. 22.

    Mettenleiter TC, Lukacs N, Rziha H-J (1985) Pseudorabies virus avirulent strains fail to express a major glycoprotein. J Virol 56: 307–311

  23. 23.

    Miller R, Iltis JP, Rapp F (1977) Differential effect of arabinofuranosylthymine on the replication of human herpesvirus. J Virol 23: 679–684

  24. 24.

    Misra V, Nelson R, Smith M (1988) Sequence of a bovine herpesvirus type-1 glycoprotein gene that is homologous to the herpes simplex gene for the glycoprotein gB. Virology 166: 542–549

  25. 25.

    Mocarski ES, Post LE, Roizman B (1980) Molecular engineering of the herpes simplex virus genome: insertion of a second L-S junction into the genome causes additional genome inversions. Cell 22: 243–255

  26. 26.

    Müller WG, Zahn RK, Arendes J, Falke D (1979) Phosphorylation of arabinofuranosyl-thymine in non-infected and herpesvirus (TK+ and TK −)-infected cells. J Gen Virol 43: 261–271

  27. 27.

    Neidhardt H, Schroder CH, Kaerner HC (1987) Herpes simplex virus type 1 glycoprotein E is not indispensable for viral infection. J Virol 61: 600–603

  28. 28.

    Okazaki K, Honda E, Minetoma T, Kumagi T (1986) Mechanism of neutralization by monoclonal antibodies to different antigenic sites on bovine herpesvirus type 1 glycoproteins. Virology 150: 260–264

  29. 29.

    Petrovskis EA, Timmins JG, Armentrout MA, Marchioli CC, Yancey RJ, Post LE (1986) DNA sequence of the gene for pseudorabies virus gp 50, a glycoprotein without N-linked glycosylation. J Virol 59: 216–223

  30. 30.

    Petrovskis EA, Timmins JG, Post LE (1986) Use of gt11 to isolate genes for two pseudorabies virus glycoproteins with homology to herpes simplex virus and varicellazoster virus glycoproteins. J Virol 60: 185–193

  31. 31.

    Rauh I, Weiland F, Fehler F, Keil GM, Mettenleiter TC (1991) Pseudorabies virus mutants lacking the essential glyco-protein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. J Virol 65: 621–631

  32. 32.

    Robbins AK, Dorney DJ, Wathen MW, Whealy ME, Gold C, Watson RJ, Holland LE, Weed SD, Levine M, Glorioso JC, Enquist LW (1987) The pseudorabies virus gII gene is closely related to gB glycoprotein gene of herpes simplex virus. J Virol 61: 2691–2701

  33. 33.

    Smiley JR, Fong BS, Leung W-C (1981) Construction of a double-jointed herpes simplex viral DNA molecule: inverted repeats are required for segment inversion, and direct repeats promote deletions. Virology 113: 345–362

  34. 34.

    Wathen MW, Wathen LMK (1984) Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. J Virol 51: 57–62

  35. 35.

    Whealy ME, Card JP, Robbins AK, Dubin JR, Rziha H-J, Enquist LW (1993) Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins. J Virol 67: 3786–3797

  36. 36.

    Xuan X, Nakamura T, Ihara T, Sato I, Tuchiya K, Nosetto E, Ishihama A, Ueda S (1995) Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus. Virus Res 36: 151–161

  37. 37.

    Zask L, Zuckermann F, Sugg N, Ben-Porat T (1992) Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission. J Virol 66: 2316–2325

  38. 38.

    Zuckermann F, Mettenleiter TC, Schreurs C, Sugg N, Ben-Porat T (1988) Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J Virol 62: 4622–4626

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Otsuka, H., Xuan, X. Construction of bovine herpesvirus-1 (BHV-1) recombinants which express pseudorabies virus (PRV) glycoproteins gB, gC, gD, and gE. Archives of Virology 141, 57–71 (1996). https://doi.org/10.1007/BF01718588

Download citation

Keywords

  • Western Blot
  • Blot Analysis
  • Western Blot Analysis
  • Thymidine
  • Thymidine Kinase